CLINICAL_TRIALS
trial_result
· 2010-06-07
Clinical Trial Update: Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)
Summary
A completed UK study (P05269) evaluated the combination of ViraferonPeg and Rebetol in hepatitis C genotype 1 patients, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Status: COMPLETED | Results posted: 2010-06-07